SARS-CoV-2: Pregnancy, Delivery and Postpartum. A short review.


  • Blanca Rosa Aguilar Uscanga Universidad de Guadalajara
  • Sheila B. Pérez-Elizondo Hospital Civil de Guadalajara
  • Jessica Guadalupe Solis Aguilar Hospital Civil de Guadalajara
  • Josue Raymundo Solis Pacheco
  • Jesús Alonso Amézcua-López
  • Celia Mariana Martínez-Gómez



Pregnancy, postpartum, lactation, SARS-CoV-2, vaccine


Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is the ninth documented coronavirus to infect humans and it is highly transmissible; has caused a global pandemic and dramatic loss of human life worldwide. Isolated in Wuhan, China in late 2019, it struck nations with significant economic and public health consequences. The International Committee on Taxonomy of Viruses (ICTV) named the virus as SARS-CoV-2 and the disease as COVID-19. However, few studies have been published on the effects that this virus can have during pregnancy, childbirth and postpartum, so the objective of this review is to alert about the possible problems that women can present during their pregnancy, and provide adequate and specialized. It has been described that SARSCoV-2 virus has a predilection for the angiotensin converting enzyme (ACE) II receptor present in pneumocytes, enterocytes and at the placental level. Placental involvement could lead to hypoperfusion and thrombosis, resulting in fetal intrauterine growth restriction and preterm delivery. Careful monitoring of pregnant patients who test positive for SARS-CoV-2 is recommended because of the potential complications that could occur in the mother and fetus. The recommendations include offering vaccines against SARS-CoV-2 to pregnant and breastfeeding women, the provision of comprehensive health care to the mother-child pair; for example, maternal support networks and establishment of successful breastfeeding, which involves the development of the maternal-neonatal bond.


Anderson P. O. (2020). Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza. Breastfeed Med. 15(3):128. doi: 10.1089/bfm.2020.29149.poa.

Angius F., Pala G., Manzin A. (2021). SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated. Frontiers in microbiology. (12):1-5. doi: 10.3389/fmicb.2021.749634

Bai L., Yang D., Wang X., et al (2020). Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). Clinical e-Health. (3):7-15. doi: 10.1016/j.ceh.2020.03.001

Bastug A., Hanifehnezhad A., Tayman C., Ozkul A., Ozbay O., Kazancioglu S., Bodur H. (2020). Virolactia in an Asymptomatic Mother with COVID-19. Breastfeed Med. 15(8):488-491. doi: 10.1089/bfm.2020.0161.

Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 7(395):809-815. doi: 10.1016/S0140-6736(20)30360-3

Chen S., Huang B., Luo D. J., Li X., Yang F., Zhao Y., Nie X., Huang B. X. (2020). Pregnancy with new coronavirus infection: a clinical characterístics and placental pathological analysis of three cases. Chinese Medical Journal. 49(5): 418-423. doi: 10.3760/cma.j.cn112151-20200225-00138.

Chu C. M., Cheng V. C., Hung I. F., Wong M. M., Chan K. H., Chan K. S., Kao R. Y., Poon L. L., Wong C. L., Guan Y., Peiris J. S., Yuen K. Y. (2004). Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 59(3):252-6. doi: 10.1136/thorax.2003.012658.

Della Gatta A. N., Rizzo R., Pilu G., Simonazzi G. (2020). Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 223(1):36-41. doi: 10.1016/j.ajog.2020.04.013.

Garcia-Flores V., Romero R., Xu Y., Theis K., Arenas-Hernandez M., Miller D., Peyvandipour A., Galaz J., Levenson D., Bhatti G., Gershater M., Pusod E., Kracht D., Florova V., Leng Y., Tao L., Faucett M., Para R., Hsu C. D., Zhang G., Tarca A. L., Pique-Regi R., Gomez-Lopez N. (2021). Maternal-Fetal Immune Responses in Pregnant Women Infected with SARS-CoV-2. Research Square. doi: 10.21203/

Halasa N. B., Olson S. M., Staat M. A., Newhams M. M., Price A. M., Boom J. A., Sahni L. C., Cameron M. A., Pannaraj P. S., Bline K. E., Bhumbra S. S., Bradford T. T., Chiotos K., Coates B. M., Cullimore M. L., Cvijanovich N. Z., Flori H. R., Gertz S. J., Heidemann S. M., Hobbs C. V., Hume J. R., Irby K., Kamidani S., Kong M., Levy E. R., Mack E. H., Maddux A. B., Michelson K. N., Nofziger R. A., Schuster J. E., Schwartz S. P., Smallcomb L., Tarquinio K. M., Walker T. C., Zinter M. S., Gilboa S. M., Polen K. N., Campbell A. P., Randolph A. G., Patel M. M. (2022) Overcoming COVID-19 Investigators; Overcoming COVID-19 Network. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 18;71(7):264-270. doi: 10.15585/mmwr.mm7107e3.

Hall V. Foulkes S., Insalata F., Kirwan P., Saei A. Atti A., Wellington E., Khawam J., Munro J. K., Cole M., Tranquillini C., Taylor‑Kerr A., Hettiarachchi N., Calbraith D., Sajedi N., I. Milligan, Y. Themistocleous D., Corrigan L., Cromey L., Price S., Stewart E., de Lacy C., Norman E., Linley A. D., Otter A., Semper J., Hewson S., D’Arcangelo M., Chand C. S., Brown T., Brooks J., Islam A., Charlett, and S. Hopkins (2022). Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection. The New England Journal of Medicine. doi: 10.1056/NEJMoa2118691

Kachikis A., Englund J. A., Singleton M., Covelli I., Drake A. L., Eckert L. O. (2021). Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout. JAMA Netw Open. 4(8): e2121310. doi: 10.1001/jamanetworkopen.2021.21310.

Lipkind H. S., Vazquez-Benitez G., DeSilva M., Vesco K. K., Ackerman-Banks C., Zhu J., Boyce T. G., Daley M. F., Fuller C. C., Getahun D., Irving S. A., Jackson L. A., Williams J. T. B., Zerbo O., McNeil M. M., Olson C. K., Weintraub E., Kharbanda E. O. (2022). Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 7;71(1):26-30. doi: 10.15585/mmwr.mm7101e1.

Mullins E., Hudak M. L., Banerjee J., Getzlaff T., Townson J., Barnette K., Playle R., Perry A., Bourne T., Lees C. (2021). Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 57(4):573-581. doi: 10.1002/uog.23619.

Nir O., Schwartz A., Toussia-Cohen S., Leibovitch L., Strauss T., Asraf K., Doolman R., Sharabi S., Cohen C., Lustig Y., Regev-Yochay G., Yinon Y. (2021). Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM. 4(1):100492. doi: 10.1016/j.ajogmf.2021.100492.

Oltean I., Tran J., Lawrence S., Ruschkowski B. A., Zeng N., Bardwell C., Nasr Y., de Nanassy J., El Demellawy D. (2021). Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review. Heliyon. 7(3): e06393. doi: 10.1016/j.heliyon.2021.e06393.

Parazzini F., Bortolus R., Mauri P. A., Favilli A., Gerli S., Ferrazzi E. (2020). Delivery in pregnant women infected with SARS-CoV-2: A fast review. Int J Gynaecol Obstet. 150(1):41-46. doi: 10.1002/ijgo.13166

Radan A. P., Baud D., Favre G., Papadia A., Surbek D., Baumann M., Raio L. (2022). Low placental weight and altered metabolic scaling after severe acute respiratory syndrome coronavirus type 2 infection during pregnancy: a prospective multicentric study. Clin Microbiol Infect. 10:S1198-743X(22)00076-3. doi: 10.1016/j.cmi.2022.02.003.

Romero-Ramírez D. S., Suárez-Hernández M. I., Fernández-Vilar A. M., Rivero-Falero M., Reyes-Millán B., González-Carretero P, Pérez M. M. L., Carretero-Pérez M., Martín-Pulido S., Pera-Villacampa L., García-Bello M. Á., Mesa-Medina O. M., Roper S. (2022) Evaluation of Adverse Effects in Nursing Mothers and Their Infants After COVID-19 mRNA Vaccination. Breastfeed Med. doi: 10.1089/bfm.2021.0256.

Salvatori G., De Rose D. U., Concato C., Alario D., Olivini N., Dotta A., Campana A. (2020). Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience. Breastfeed Med. 15(5):347-348 doi: 10.1089/bfm.2020.0095.

Shereen M. A., Khan S., Kazmi A., Bashir N., Siddique R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 16 (24):91-98. doi: 10.1016/j.jare.2020.03.005

Stuebe A. Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research. (2020a). Breastfeed Med. 2020a;15(6):423-424. doi: 10.1089/bfm.2020.29155.ams423

Stuebe A. Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm. (2020b) Breastfeed Med. 15(5):351-352. doi: 10.1001/jamanetworkopen.2021.21310.

World Health Organization. (2022, April 7). Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 19 March 2020.




How to Cite

Aguilar Uscanga, B. R., Pérez-Elizondo, S. B. ., Solis Aguilar, J. G. ., Solis Pacheco, J. R., Amézcua-López, J. A., & Martínez-Gómez, C. M. (2022). SARS-CoV-2: Pregnancy, Delivery and Postpartum. A short review. European Journal of Applied Sciences, 10(2), 634–641.